Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Truncation in Survival Analysis01:09

Truncation in Survival Analysis

169
Truncation in survival analysis refers to the exclusion of individuals or events from the dataset based on specific criteria related to the time of the event. This exclusion can happen in two primary forms: left truncation and right truncation.
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
169
Censoring Survival Data01:09

Censoring Survival Data

65
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
65
Hazard Rate01:11

Hazard Rate

91
The hazard rate, also known as the hazard function or failure rate, is a statistical measure used to describe the instantaneous rate at which an event occurs, given that the event has not yet happened. From a probabilistic perspective, it represents the likelihood that a subject will experience the event in a very small time interval, conditional on surviving up to the beginning of that interval. In terms of frequency, the hazard rate can be viewed as the ratio of the number of events to the...
91
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

155
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
155
The Mantel-Cox Log-Rank Test01:19

The Mantel-Cox Log-Rank Test

314
The Mantel-Cox log-rank test is a widely used statistical method for comparing the survival distributions of two groups. It tests whether a statistically significant difference exists in survival times between the groups without assuming a specific distribution for the survival data, making it a non-parametric test. This flexibility makes the log-rank test particularly valuable in medical research and other fields where the timing of an event, such as death or disease recurrence, is of...
314
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

121
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
121

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Real-World Evaluation of Guideline-Directed Treatments in Patients With Obstructive Hypertrophic Cardiomyopathy in Germany.

Clinical Medicine Insights. Cardiology·2026
Same author

Elevated filling pressures are associated with poor long-term graft survival after pediatric heart transplantation.

Transplant international : official journal of the European Society for Organ Transplantation·2026
Same author

Use of the Online Portal "Embryotox" in Routine Health Care: Mixed Methods Study.

Journal of medical Internet research·2026
Same author

Anthelmintic medication with focus on first-trimester exposure: an evaluation of pregnancy outcomes based on the Embryotox cohort.

Scientific reports·2026
Same author

A two-stage landmark competing risks approach: A prediction model for predicting preterm preeclampsia in a retrospective pregnancy cohort.

Pregnancy hypertension·2026
Same author

Prognostic Value and Sex-Related Differences in Chest Pain in Patients with Acute Pulmonary Embolism: A Prospective Cohort Study Beyond Myocardial Ischemia.

Journal of clinical medicine·2026

相关实验视频

Updated: Jun 9, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K

标志着左截止的竞争风险数据的地标.

Theresa Unseld1, Tobias Bluhmki2, Jan Beyersmann2

  • 1Institute of Medical Biometry and Epidemiology, Ulm University, Helmholtzstraße 22, Ulm, Germany.

Biometrical journal. Biometrische Zeitschrift
|October 29, 2024
PubMed
概括
此摘要是机器生成的。

路标提供了在怀孕期间药物安全性的动态预测,比较了诸如自发性流产 (SAB) 等不良结果的风险与诺基诺暴露. 虽然地标显示了一些效应减弱,但结果与以前的发现一致.

关键词:
竞争的风险竞争的风险.标志着土地的标志着土地的标志左侧的切断是左侧的切断.怀孕数据 怀孕数据时间依赖的共变量.

更多相关视频

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.1K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

223

相关实验视频

Last Updated: Jun 9, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.1K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

223

科学领域:

  • 流行病学 流行病学
  • 生物统计学 生物统计学
  • 药物监督 药物监督 药物监督

背景情况:

  • 在怀孕期间评估药物安全性需要对不良结果进行准确的动态预测.
  • 复杂的多状态模型可能对实时风险评估具有挑战性.

研究的目的:

  • 开发和评估用于分析与怀孕药物安全性竞争风险的左截断数据的标志性方法.
  • 用模拟和现实世界的数据,将地标预测与传统方法进行比较.

主要方法:

  • 将标志技术应用于德国胚胎毒素药监督研究所的队列研究.
  • 模拟研究比较地标,非参数多态模型和考克斯回归.
  • 对自发堕胎 (SAB) 和选择性终止怀孕的累积发病率的分析.

主要成果:

  • 标志性估计显示了一些减弱,但仍然接近多州模型估计.
  • 在怀孕早期暴露于化诺可能会增加选择性终止妊娠的累积发病率.
  • 没有显著增加自发流产 (SAB) 风险或累积发病率被观察到在诺基诺暴露的妇女.

结论:

  • 里程碑是复杂场景中的动态预测的可行替代方案,如怀孕药物安全性.
  • 这些发现支持了先前的分析,表明在第一季度暴露在化类中,SAB风险没有增加.
  • 诺基诺暴露与选择性终止怀孕之间的潜在联系需要进一步调查.